• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9 诱导的人类单条染色体的转基因插入和端粒相关的截断用于 CHO 和 A9 细胞的染色体工程。

CRISPR/Cas9-induced transgene insertion and telomere-associated truncation of a single human chromosome for chromosome engineering in CHO and A9 cells.

机构信息

Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.

Chromosome Engineering Research Center, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.

出版信息

Sci Rep. 2017 Oct 6;7(1):12739. doi: 10.1038/s41598-017-10418-7.

DOI:10.1038/s41598-017-10418-7
PMID:28986519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5630592/
Abstract

Chromosome engineering techniques including gene insertion, telomere-associated truncation and microcell-mediated chromosome transfer (MMCT) are powerful tools for generation of humanised model animal, containing megabase-sized genomic fragments. However, these techniques require two cell lines: homologous recombination (HR)-proficient DT40 cells for chromosome modification, and CHO cells for transfer to recipient cells. Here we show an improved technique using a combination of CRISPR/Cas9-induced HR in CHO and mouse A9 cells without DT40 cells following MMCT to recipient cells. Transgene insertion was performed in CHO cells with the insertion of enhanced green fluorescence protein (EGFP) using CRISPR/Cas9 and a circular targeting vector containing two 3 kb HR arms. Telomere-associated truncation was performed in CHO cells using CRISPR/Cas9 and a linearised truncation vector containing a single 7 kb HR arm at the 5' end, a 1 kb artificial telomere at the 3' end. At least 11% and 6% of the targeting efficiency were achieved for transgene insertion and telomere-associated truncation, respectively. The transgene insertion was also confirmed in A9 cells (29%). The modified chromosomes were transferrable to other cells. Thus, this CHO and A9 cell-mediated chromosome engineering using the CRISPR/Cas9 for direct transfer of the modified chromosome is a rapid technique that will facilitate chromosome manipulation.

摘要

染色体工程技术包括基因插入、端粒相关截断和微细胞介导的染色体转移(MMCT),是生成含有兆碱基大小基因组片段的人源化模型动物的有力工具。然而,这些技术需要两种细胞系:用于染色体修饰的同源重组(HR)高效 DT40 细胞,以及用于转移到受体细胞的 CHO 细胞。在这里,我们展示了一种改进的技术,该技术结合了 CRISPR/Cas9 诱导的 CHO 和小鼠 A9 细胞中的 HR,而无需在 MMCT 到受体细胞后使用 DT40 细胞。通过 CRISPR/Cas9 和包含两个 3kb HR 臂的环状靶向载体,在 CHO 细胞中进行了转基因插入,插入了增强型绿色荧光蛋白(EGFP)。在 CHO 细胞中使用 CRISPR/Cas9 和包含 5'端单个 7kb HR 臂、3'端 1kb 人工端粒的线性化截断载体进行了端粒相关截断。转基因插入和端粒相关截断的靶向效率分别至少达到 11%和 6%。转基因插入也在 A9 细胞中得到了证实(29%)。修饰后的染色体可转移到其他细胞中。因此,这种使用 CRISPR/Cas9 直接转移修饰染色体的 CHO 和 A9 细胞介导的染色体工程是一种快速技术,将促进染色体操作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/5ed3f9165e74/41598_2017_10418_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/ffa3b6fd57e6/41598_2017_10418_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/fd59c6d43bef/41598_2017_10418_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/62982bed5cd9/41598_2017_10418_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/5ed3f9165e74/41598_2017_10418_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/ffa3b6fd57e6/41598_2017_10418_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/fd59c6d43bef/41598_2017_10418_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/62982bed5cd9/41598_2017_10418_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b23/5630592/5ed3f9165e74/41598_2017_10418_Fig4_HTML.jpg

相似文献

1
CRISPR/Cas9-induced transgene insertion and telomere-associated truncation of a single human chromosome for chromosome engineering in CHO and A9 cells.CRISPR/Cas9 诱导的人类单条染色体的转基因插入和端粒相关的截断用于 CHO 和 A9 细胞的染色体工程。
Sci Rep. 2017 Oct 6;7(1):12739. doi: 10.1038/s41598-017-10418-7.
2
Site-specific chromosomal gene insertion: Flp recombinase versus Cas9 nuclease.位点特异性染色体基因插入:Flp 重组酶与 Cas9 核酸酶。
Sci Rep. 2017 Dec 19;7(1):17771. doi: 10.1038/s41598-017-17651-0.
3
Homologous Recombination-Independent Large Gene Cassette Knock-in in CHO Cells Using TALEN and MMEJ-Directed Donor Plasmids.利用TALEN和MMEJ导向的供体质粒在CHO细胞中进行不依赖同源重组的大基因盒敲入
Int J Mol Sci. 2015 Oct 9;16(10):23849-66. doi: 10.3390/ijms161023849.
4
Targeted knock-in of an scFv-Fc antibody gene into the hprt locus of Chinese hamster ovary cells using CRISPR/Cas9 and CRIS-PITCh systems.使用CRISPR/Cas9和CRIS-PITCh系统将单链抗体片段-融合蛋白(scFv-Fc)抗体基因靶向敲入中国仓鼠卵巢细胞的次黄嘌呤磷酸核糖转移酶(hprt)基因座。
J Biosci Bioeng. 2018 May;125(5):599-605. doi: 10.1016/j.jbiosc.2017.12.003. Epub 2017 Dec 30.
5
Development of a multiple-gene-loading method by combining multi-integration system-equipped mouse artificial chromosome vector and CRISPR-Cas9.通过结合多整合系统装备的小鼠人工染色体载体和 CRISPR-Cas9 开发多基因加载方法。
PLoS One. 2018 Mar 5;13(3):e0193642. doi: 10.1371/journal.pone.0193642. eCollection 2018.
6
Highly efficient CRISPR/Cas9-mediated transgene knockin at the H11 locus in pigs.高效的CRISPR/Cas9介导的转基因在猪H11位点的敲入。
Sci Rep. 2015 Sep 18;5:14253. doi: 10.1038/srep14253.
7
Controlling Ratios of Plasmid-Based Double Cut Donor and CRISPR/Cas9 Components to Enhance Targeted Integration of Transgenes in Chinese Hamster Ovary Cells.控制基于质粒的双切割供体和 CRISPR/Cas9 组件的比例,以增强转染基因在中华仓鼠卵巢细胞中的靶向整合。
Int J Mol Sci. 2021 Feb 27;22(5):2407. doi: 10.3390/ijms22052407.
8
Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35.通过 CRISPR/Cas9 介导的 C12orf35 位点特异性整合,快速开发稳定的转染 CHO 细胞系。
Appl Microbiol Biotechnol. 2018 Jul;102(14):6105-6117. doi: 10.1007/s00253-018-9021-6. Epub 2018 May 22.
9
Highly Efficient Microcell-Mediated Transfer of HACs Containing a Genomic Region of Interest into Mammalian Cells.高效的微细胞介导转移技术将含有目的基因组区域的 HAC 导入哺乳动物细胞。
Curr Protoc. 2021 Sep;1(9):e236. doi: 10.1002/cpz1.236.
10
Efficient transgene insertion in a pseudorabies virus vector by CRISPR/Cas9 and marker rescue-enforced recombination.通过 CRISPR/Cas9 和标记拯救增强型重组实现伪狂犬病病毒载体中的高效转基因插入。
J Virol Methods. 2018 Dec;262:38-47. doi: 10.1016/j.jviromet.2018.09.009. Epub 2018 Sep 21.

引用本文的文献

1
Rapid human genomic DNA cloning into mouse artificial chromosome via direct chromosome transfer from human iPSC and CRISPR/Cas9-mediated translocation.通过源自人诱导多能干细胞的直接染色体转移和 CRISPR/Cas9 介导的易位,快速将人类基因组 DNA 克隆到小鼠人工染色体中。
Nucleic Acids Res. 2024 Feb 9;52(3):1498-1511. doi: 10.1093/nar/gkad1218.
2
Aneuploidy in human cancer: new tools and perspectives.人类癌症中的非整倍体:新工具和新视角。
Trends Genet. 2023 Dec;39(12):968-980. doi: 10.1016/j.tig.2023.09.002. Epub 2023 Sep 29.
3
Modeling specific aneuploidies: from karyotype manipulations to biological insights.

本文引用的文献

1
Moving toward a higher efficiency of microcell-mediated chromosome transfer.向更高效率的微细胞介导的染色体转移迈进。
Mol Ther Methods Clin Dev. 2016 Jun 22;3:16043. doi: 10.1038/mtm.2016.43. eCollection 2016.
2
Development of a Safeguard System Using an Episomal Mammalian Artificial Chromosome for Gene and Cell Therapy.利用附加型哺乳动物人工染色体开发用于基因和细胞治疗的保障系统
Mol Ther Nucleic Acids. 2015 Dec 15;4(12):e272. doi: 10.1038/mtna.2015.45.
3
Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome.
模拟特定的非整倍体:从染色体组操作到生物学见解。
Chromosome Res. 2023 Aug 29;31(3):25. doi: 10.1007/s10577-023-09735-7.
4
Oncogene-like addiction to aneuploidy in human cancers.人类癌症中类似癌基因的非整倍体成瘾。
Science. 2023 Aug 25;381(6660):eadg4521. doi: 10.1126/science.adg4521.
5
Cancer aneuploidies are shaped primarily by effects on tumour fitness.癌症非整倍体主要由对肿瘤适应性的影响所决定。
Nature. 2023 Jul;619(7971):793-800. doi: 10.1038/s41586-023-06266-3. Epub 2023 Jun 28.
6
Human artificial chromosome carrying 3p21.3-p22.2 region suppresses hTERT transcription in oral cancer cells.携带 3p21.3-p22.2 区域的人源人工染色体抑制口腔癌细胞中端粒酶逆转录酶转录。
Chromosome Res. 2023 Jun 24;31(3):17. doi: 10.1007/s10577-023-09726-8.
7
Oncogene-like addiction to aneuploidy in human cancers.人类癌症中对非整倍体的癌基因样依赖。
bioRxiv. 2023 Jan 10:2023.01.09.523344. doi: 10.1101/2023.01.09.523344.
8
CRISPR/Cas: A New Tool in the Research of Telomeres and Telomerase as Well as a Novel Form of Cancer Therapy.CRISPR/Cas:端粒和端粒酶研究的新工具以及一种新型的癌症治疗方法。
Int J Mol Sci. 2022 Mar 10;23(6):3002. doi: 10.3390/ijms23063002.
9
Panel of human cell lines with human/mouse artificial chromosomes.带有人类/小鼠人工染色体的人类细胞系面板。
Sci Rep. 2022 Feb 22;12(1):3009. doi: 10.1038/s41598-022-06814-3.
10
Targeting chromosome trisomy for chromosome editing.靶向染色体三体进行染色体编辑。
Sci Rep. 2021 Sep 10;11(1):18054. doi: 10.1038/s41598-021-97580-1.
将微细胞融合重新定向用于以受体细胞为导向的人类人工染色体转移。
BMC Biotechnol. 2015 Jun 19;15:58. doi: 10.1186/s12896-015-0142-z.
4
CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.CRISPR/Cas9介导的中国仓鼠卵巢细胞工厂基因组工程:应用与展望
Biotechnol J. 2015 Jul;10(7):979-94. doi: 10.1002/biot.201500082. Epub 2015 Jun 9.
5
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.通过抑制非同源末端连接提高CRISPR-Cas9精确基因组编辑的效率
Nat Biotechnol. 2015 May;33(5):538-42. doi: 10.1038/nbt.3190. Epub 2015 Mar 23.
6
Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway.由CRISPR/Cas9和同源定向DNA修复途径介导的CHO细胞中的位点特异性整合。
Sci Rep. 2015 Feb 25;5:8572. doi: 10.1038/srep08572.
7
A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges.一条从染色体转移到工程化的途径,可产生用于应对各种生物医学挑战的人类和小鼠人工染色体。
Chromosome Res. 2015 Feb;23(1):111-33. doi: 10.1007/s10577-014-9459-z.
8
Genome editing. The new frontier of genome engineering with CRISPR-Cas9.基因组编辑。CRISPR-Cas9 技术引领的基因组工程新前沿。
Science. 2014 Nov 28;346(6213):1258096. doi: 10.1126/science.1258096.
9
A novel system for simultaneous or sequential integration of multiple gene-loading vectors into a defined site of a human artificial chromosome.一种用于将多个基因加载载体同时或顺序整合到人类人工染色体特定位点的新型系统。
PLoS One. 2014 Oct 10;9(10):e110404. doi: 10.1371/journal.pone.0110404. eCollection 2014.
10
Down syndrome-associated haematopoiesis abnormalities created by chromosome transfer and genome editing technologies.通过染色体转移和基因组编辑技术产生的唐氏综合征相关造血异常。
Sci Rep. 2014 Aug 27;4:6136. doi: 10.1038/srep06136.